Specialties
Reports that name this provider
- Psilocybin Treatment Legality in Brazil
- ANVISA authorization AE No. 30/2024 and import permit AI 067/2025 for preclinical psilocybin pharmaceutical development; partnership with Federal University of Campina Grande (UFCG) and Certbio laboratory; nanoencapsulation formulation research; clinical arm is Instituto Alma Viva